Toradol, a nonsteroidal anti-inflammatory drug (NSAID) also known as ketorolac, is frequently used for short-term pain management. The onset of its analgesic effect is a key consideration for both medical professionals and patients. While individual responses can vary, understanding the typical timeframe for its efficacy is crucial for effective pain control.
The swift action of ketorolac is a primary advantage in acute pain scenarios, such as post-operative discomfort or musculoskeletal injuries. Its ability to provide relatively rapid relief can minimize the need for opioid analgesics, potentially reducing the risk of opioid-related side effects. Its development and use represent a significant option for managing pain in specific clinical settings. The duration of effectiveness is limited to five days due to potential side effects.